HCA Healthcare, Inc. HCA

HCA Healthcare has implemented a multi-year financial resiliency program focused on mitigating the impact of health insurance exchange headwinds. This program has four key areas: revenue integrity, variable and fixed cost efficiencies, and capacity management. It leverages internal/external benchmarking, advanced analytics, digital transformation with AI and automation, and expanded shared service platforms. The company is confident in achieving $400 million in incremental cost savings in 2026 from these initiatives, which are seen as a cultural dynamic rather than a one-time^📎 event.

The company anticipates an adverse impact of $600 million to $900 million on adjusted EBITDA in 2026 due to administrative reforms, the One Big Beautiful Bill Act, and the expiration of enhanced premium tax credits. HICS volumes represented approximately 8% of admissions and 10% of revenue in 2025. The model contemplates a 15% to 20% decline in HICS volumes for 2026, with 15% to 20% migrating to employee-sponsored coverage and the remainder to uninsured. Uninsured patients are expected to have a 30% decline in utilization compared to when they had exchange coverage.

HCA continues to invest significantly in outpatient facility development, adding approximately 100 business units to its outpatient footprint in the past year. The company aims for 18 to 20 outpatient facilities per hospital by the end of the decade. Outpatient revenue growth exceeded inpatient revenue growth in Q4 FY25, driven by solid performance across emergency services, outpatient surgery (hospital-based and ASCs), ambulatory platforms, and other hospital-based outpatient services. The pipeline for outpatient acquisitions is also stronger than in recent years.

HCA is heavily investing in its technology agenda, including accelerating its electronic health record transition to standardize datasets across hospitals. The AI strategy is organized into three domains: administrative (revenue cycle, HR, IT, supply chain for efficiencies), operational (throughput, asset productivity, scheduling, staffing, OR management), and clinical (supporting physicians with data-driven insights and nurses with tools for safer, more efficient patient environments). The company expects AI to create significant value in quality, efficiency, and management effectiveness.

The company has seen accelerated M&A opportunities in the outpatient space, focusing on in-market transactions complementary to existing networks. While open to hospital and tax-exempt hospital acquisitions, no significant opportunities have presented themselves recently. HCA's strong balance sheet and scaled capabilities position it well for synergistic assimilations. The capital spending range has been increased to $5 billion to $5.5 billion for 2026, with almost $7 billion in approved projects in the pipeline, primarily for inpatient capacity and outpatient development.

HCA has launched digital integration engagements with major payers, focusing on electronic data exchange, administrative simplification, and dispute resolution. These initiatives aim to improve relationships with payers and enhance revenue cycle management. Benefits include more timely claims payments and mitigation of denials. A reduction in net days in accounts receivable in Q4 FY25 reflects the positive impact of these data-sharing efforts.

Under the One Big Beautiful Bill Act, all 50 states have been allocated program funding, but details on timing, structure, and distribution are largely unknown. HCA views this as a potential opportunity, given that roughly 15% of its hospitals are rural and it has programs providing services in rural communities. The company is actively engaged with state and federal partners on program design but has not reflected any potential impact in its 2026 guidance due to remaining uncertainty.